Sana Biotechnology SANA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$47.21M+19.7% | -$58.83M-39.6% | -$42.15M+55.1% | -$93.8M-89.9% | -$49.39M-0.7% | ||
| $2.39M— | —— | $3.2M+10.3% | $2.9M-20.5% | $3.65M— | ||
| $5.66M-10.7% | $6.34M+15.7% | $5.48M-17.4% | $6.63M-5.6% | $7.02M+9.1% | ||
| $454K+340% | -$189K+47.1% | -$357K— | —— | -$4.22M-285% | ||
| -$7.09M— | —— | —— | -$2.99M+66.4% | -$8.89M-194% | ||
| -$1.63M— | —— | -$1.12M— | —— | -$1.37M— | ||
| $2.62M-15.6% | $3.1M+48.9% | $2.08M-17.5% | $2.52M-22.9% | $3.27M+1.4% | ||
| $2.47M+3.2% | $2.39M+3.2% | $2.32M+3.9% | $2.23M-0.1% | $2.23M+2.4% | ||
| $10.75M+25.3% | $8.58M— | —— | $6.3M+238% | $1.86M+165% | ||
| -$37.38M-14.5% | -$32.64M-10.9% | -$29.43M+11.1% | -$33.1M+32.0% | -$48.66M-3.2% | ||
| $288K-67.0% | $873K+2,029% | $41K— | —— | $136K-68.8% | ||
| $248K-62.5% | $661K+386% | $136K-64.4% | $382K+51.0% | $253K— | ||
| $49.44M+400% | -$16.5M+65.7% | -$48.03M-725% | $7.68M-53.7% | $16.6M-64.7% | ||
| $59K-99.6% | $16.68M-84.8% | $109.47M— | $0-100% | $1.13M— | ||
| -$128K-101% | $17.65M-83.9% | $109.54M+19,426% | $561K-42.9% | $982K+52.7% | ||
| $11.93M+138% | -$31.49M— | —— | -$24.86M+20.0% | -$31.07M— | ||
| $10.75M+25.3% | $8.58M— | —— | $6.3M+238% | $1.86M+165% | ||
| -$2.31M-142% | $5.51M+7.8% | $5.12M+29.1% | $3.96M+4,160% | $93K+101% | ||
| $2.39M— | —— | $3.2M+10.3% | $2.9M-20.5% | $3.65M— | ||
| -$7.09M— | —— | —— | -$2.99M+66.4% | -$8.89M-194% | ||
| $1.5M+2.6% | $1.46M0.0% | $1.46M+50.0% | $972K+209% | -$891K+49.1% | ||
| -$1.63M— | —— | -$1.12M— | —— | -$1.37M— | ||
| $2.47M+3.2% | $2.39M+3.2% | $2.32M+3.9% | $2.23M-0.1% | $2.23M+2.4% | ||
| $2.62M-15.6% | $3.1M+48.9% | $2.08M-17.5% | $2.52M-22.9% | $3.27M+1.4% | ||
| $248K-62.5% | $661K+386% | $136K-64.4% | $382K+51.0% | $253K— | ||
| $96K— | —— | —— | —— | $60K— | ||
| $91K— | —— | —— | —— | $85K— | ||
| $59K-94.4% | $1.06M+575% | $157K-52.9% | $333K-70.5% | $1.13M+61.2% | ||
| $0— | —— | —— | —— | $891K+440% | ||
| —— | -$681K0.0% | -$681K0.0% | -$681K0.0% | -$681K+62.5% | ||
| -$37.67M-12.4% | -$33.51M-13.7% | -$29.47M+10.7% | -$32.99M+32.4% | -$48.79M-2.5% | ||
| -$37.67M-12.4% | -$33.51M-13.7% | -$29.47M+10.7% | -$32.99M+32.4% | -$48.79M-2.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Sana Biotechnology generate?
- Sana Biotechnology (SANA) generated -$132.6M in operating cash flow over the trailing twelve months.
- What is Sana Biotechnology's free cash flow?
- After $1.3M of capital expenditures, Sana Biotechnology's free cash flow was -$133.6M over the trailing twelve months, up 40.3% year over year.
- Where does Sana Biotechnology's cash flow data come from?
- Every line is extracted from Sana Biotechnology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.